yttrium radioisotopes has been researched along with Androgen-Independent Prostatic Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bibok, A; Frakes, J; Hoffe, S; Jain, R; Kis, B; Parikh, N; Zhang, J | 1 |
Bander, NH; Ho, B; Molina, A; Nanus, DM; Nauseef, JT; Osborne, JR; Stangl-Kremser, J; Sternberg, CN; Sun, M; Tagawa, S; Thomas, J | 1 |
Aggarwal, R; Behr, SC; Deller, TW; Evans, MJ; Flavell, RR; Jivan, S; Khalighi, MM; Kohi, MP; Seo, Y; Wang, YH; Wangerin, KA | 1 |
3 other study(ies) available for yttrium radioisotopes and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
Yttrium-90 Radioembolization for Liver-Dominant Metastatic Prostate Cancer: A Case Series.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Yttrium Radioisotopes | 2022 |
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
Topics: Actinium; Humans; Lymphocytes; Male; Neutrophils; Prognosis; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Quantitative and Qualitative Improvement of Low-Count [
Topics: Algorithms; Citrates; Gallium; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Microspheres; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Signal-To-Noise Ratio; Yttrium Radioisotopes | 2020 |